Rheumatology

Severe cryoglobulinemic vasculitis responds to rituximab therapy

Reuters Health • The Doctor's Channel Daily Newscast

Severe cryoglobulinemic vasculitis responds to rituximab therapy
NEW YORK (Reuters Health) – Rituximab monotherapy is “a very good option” for severe cryoglobulinemic vasculitis (CV), according to the authors of an Italian study published online December 6 in Arthritis & Rheumatism. “RTX (rituximab) is superior, also in the long term, to standard...

Rituximab may be effective for systemic rheumatoid vasculitis

Reuters Health • The Doctor's Channel Daily Newscast

Rituximab may be effective for systemic rheumatoid vasculitis
NEW YORK (Reuters Health) – Patients with systemic vasculitis associated with rheumatoid arthritis respond well to rituximab therapy, French investigators report in Arthritis Care & Research online November 10. “Complete remission of SRV was achieved in nearly three quarters of patients receiving...

Diuretics increase gout risk by raising serum urate levels

Reuters Health • The Doctor's Channel Daily Newscast

Diuretics increase gout risk by raising serum urate levels
NEW YORK (Reuters Health) – Diuretic use is associated with an increased incidence of gout, an association mediated by increases in serum urate levels, according to findings published in the September 27th online Arthritis & Rheumatism. Both hypertension and diuretic use have been associated with an...

An Option for Osteoarthritis Treatment

Hydroxychloroquine lowers HbA1c

Low-Dose Corticosteroids for RA

Next Page »